Company news

Insight Molecular Diagnostics Inc. news in 2026

Insight Molecular Diagnostics Inc.'s news releases, calls and decks from 2026, newest first.

View company

iMDx to Release Third Quarter Results on November 16, 2026

November 5, 2026

iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch

October 14, 2026

iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings

October 12, 2026

iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

September 2, 2026

IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx

August 10, 2026

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

August 4, 2026

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

July 22, 2026

IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper

June 29, 2026

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

June 22, 2026

Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry

June 16, 2026

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

June 10, 2026

iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress

June 8, 2026

IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization

May 13, 2026

iMDx to Release First Quarter 2026 Results on May 13, 2026

May 6, 2026

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

March 26, 2026

IMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

March 23, 2026

iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

March 20, 2026

Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score

March 13, 2026

Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission

March 2, 2026

iMDx Announces $26.0 Million Registered Direct Offering

February 10, 2026

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

January 13, 2026

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation

January 7, 2026

iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch

January 6, 2026

iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion

January 5, 2026

Calls in 2026

Decks in 2026